Deutsche Bank Aktiengesellschaft Has Lowered Expectations for Clorox (NYSE:CLX) Stock Price

Clorox (NYSE:CLX) had its price objective lowered by equities research analysts at Deutsche Bank Aktiengesellschaft from $114.00 to $112.00 in a report released on Wednesday,MarketScreener reports. The firm presently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s price target would indicate a potential downside of 4.76% from the stock’s current price.

Several other equities analysts have also recently commented on the stock. UBS Group lowered their price target on shares of Clorox from $119.00 to $115.00 and set a “neutral” rating on the stock in a report on Wednesday, January 14th. Evercore ISI lowered their target price on Clorox from $132.00 to $115.00 and set an “underperform” rating on the stock in a research note on Wednesday. Zacks Research raised Clorox from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Wells Fargo & Company lifted their price target on Clorox from $108.00 to $115.00 and gave the company an “equal weight” rating in a report on Friday, January 23rd. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a research note on Friday, January 9th. One analyst has rated the stock with a Buy rating, ten have issued a Hold rating and five have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Reduce” and an average price target of $117.93.

Clorox Trading Down 0.1%

NYSE:CLX opened at $117.59 on Wednesday. The stock has a market cap of $14.22 billion, a PE ratio of 19.21, a price-to-earnings-growth ratio of 0.57 and a beta of 0.59. Clorox has a fifty-two week low of $96.66 and a fifty-two week high of $159.04. The company has a debt-to-equity ratio of 71.03, a current ratio of 0.74 and a quick ratio of 0.50. The stock’s 50-day moving average is $105.58 and its two-hundred day moving average is $114.01.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $1.39 EPS for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a return on equity of 383.01% and a net margin of 11.17%.The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the prior year, the business posted $1.55 earnings per share. The business’s revenue for the quarter was down .8% compared to the same quarter last year. As a group, equities research analysts forecast that Clorox will post 7.15 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Pierre R. Breber bought 4,000 shares of the business’s stock in a transaction on Friday, November 21st. The stock was purchased at an average price of $104.13 per share, with a total value of $416,520.00. Following the transaction, the director directly owned 13,000 shares in the company, valued at approximately $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.63% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Clorox

A number of institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. boosted its stake in Clorox by 1.7% during the 2nd quarter. Vanguard Group Inc. now owns 15,845,496 shares of the company’s stock valued at $1,902,569,000 after purchasing an additional 272,420 shares during the period. State Street Corp lifted its holdings in shares of Clorox by 3.5% during the third quarter. State Street Corp now owns 8,434,277 shares of the company’s stock worth $1,039,946,000 after buying an additional 282,794 shares during the last quarter. Invesco Ltd. boosted its position in shares of Clorox by 23.1% in the third quarter. Invesco Ltd. now owns 3,995,590 shares of the company’s stock valued at $492,656,000 after acquiring an additional 750,415 shares during the period. Van ECK Associates Corp grew its stake in shares of Clorox by 93.9% in the third quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock worth $334,139,000 after acquiring an additional 1,312,471 shares during the last quarter. Finally, Two Sigma Investments LP grew its stake in shares of Clorox by 33.8% in the third quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock worth $214,564,000 after acquiring an additional 439,797 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox News Roundup

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Morgan Stanley raised its price target to $136 (equal-weight), signaling meaningful upside versus the current level and providing buy-side support. Article Title
• Positive Sentiment: Jefferies kept a Buy rating and a high target (~$151), reinforcing a bullish view on longer-term recovery and giving investors a favorable risk/reward case. Article Title
• Neutral Sentiment: Clorox reiterated its 2026 outlook despite mixed Q2 results, which limits downside if management delivers on guidance and execution. Article Title
• Neutral Sentiment: Clorox will present at the CAGNY conference (Feb. 19), offering investors a near-term opportunity for management to outline strategy and provide more color on ERP integration and potential M&A (GOJO). Article Title
• Negative Sentiment: Q2 results were mixed: adjusted EPS missed estimates ($1.39 vs. $1.43), organic sales fell year-over-year, and margin pressure from higher costs and ERP-related expenses was highlighted — primary near-term negative catalyst. Article Title
• Negative Sentiment: Evercore cut its target sharply to $115 and kept an Underperform rating, increasing sell-side pressure and signalling concerns about near-term profitability. Article Title
• Negative Sentiment: Deutsche Bank trimmed its target to $112 (hold), and TD Cowen’s $111 target (hold) also implies downside — several shops are skeptical on margins and the ERP/integration timeline. Article Title Article Title
• Negative Sentiment: BofA flagged margin uncertainty after the Q2 miss even while nudging its target to $112 — a reminder margins and execution (inventory reset, ERP) are the biggest risks near term. Article Title

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.